Financhill
Sell
50

MRUS Quote, Financials, Valuation and Earnings

Last price:
$96.22
Seasonality move :
30.55%
Day range:
$96.01 - $96.27
52-week range:
$33.19 - $96.28
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
120.82x
P/B ratio:
9.41x
Volume:
1.6M
Avg. volume:
1.4M
1-year change:
111.54%
Market cap:
$7.3B
Revenue:
$36.1M
EPS (TTM):
-$5.33

Analysts' Opinion

  • Consensus Rating
    Merus NV has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 14 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $97.00, Merus NV has an estimated upside of 0.92% from its current price of $96.22.
  • Price Target Downside
    According to analysts, the lowest downside price target is $97.00 representing 100% downside risk from its current price of $96.22.

Fair Value

  • According to the consensus of 16 analysts, Merus NV has 0.92% upside to fair value with a price target of $97.00 per share.

MRUS vs. S&P 500

  • Over the past 5 trading days, Merus NV has overperformed the S&P 500 by 0.1% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Merus NV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Merus NV has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Merus NV reported revenues of $12.2M.

Earnings Growth

  • Merus NV has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Merus NV reported earnings per share of -$1.26.
Enterprise value:
6.7B
EV / Invested capital:
8.47x
Price / LTM sales:
120.82x
EV / EBIT:
--
EV / Revenue:
117.77x
PEG ratio (5yr expected):
-0.49x
EV / Free cash flow:
-20.48x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$45.6M
Return On Assets:
-44.89%
Net Income Margin (TTM):
-673.31%
Return On Equity:
-53.47%
Return On Invested Capital:
-52.67%
Operating Margin:
-794.06%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $45.7M $35.9M $56.6M $11.8M $12.2M
Gross Profit -- $7.3M $45.6M -- $11.5M
Operating Income -$162.7M -$231M -$371.2M -$72.2M -$96.5M
EBITDA -$160.4M -$228.5M -$368.8M -$71.6M -$95.8M
Diluted EPS -$3.72 -$3.91 -$5.33 -$1.46 -$1.26
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $319.7M $368.2M $404.8M $666.3M $691.9M
Total Assets $355.9M $415M $492.2M $844.7M $904.2M
Current Liabilities $71.5M $64.2M $64.3M $80.1M $86.8M
Total Liabilities $150.2M $116.2M $98.8M $141.4M $129.3M
Total Equity $205.8M $298.8M $393.4M $703.3M $774.9M
Total Debt $4.2M $11.3M $10.5M $9.3M $9.6M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$139.6M -$155.3M -$325M -$81.8M -$90.1M
Cash From Investing -$24.2M -$145.8M -$89.7M -$135.2M $224.1K
Cash From Financing $231.6M $489.8M $358.2M $17.9M $8.9M
Free Cash Flow -$145.8M -$157.1M -$325.6M -$82.1M -$90.4M
MRUS
Sector
Market Cap
$7.3B
$28.4M
Price % of 52-Week High
99.83%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-5.03%
-1.32%
1-Year Price Total Return
108.01%
-22.19%
Beta (5-Year)
1.061
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $96.06
200-day SMA
Buy
Level $63.81
Bollinger Bands (100)
Buy
Level 65.52 - 94.64
Chaikin Money Flow
Buy
Level 40.7M
20-day SMA
Buy
Level $95.86
Relative Strength Index (RSI14)
Buy
Level 73.94
ADX Line
Buy
Level 62.3
Williams %R
Neutral
Level -24.6154
50-day SMA
Buy
Level $94.06
MACD (12, 26)
Buy
Level 0.96
25-day Aroon Oscillator
Buy
Level 48
On Balance Volume
Neutral
Level 96.3M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (10.5692)
Sell
CA Score (Annual)
Level (-1.0035)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.3384)
Buy
Piotroski F Score (Annual)
Level (5)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.

Stock Forecast FAQ

In the current month, MRUS has received 2 Buy ratings 14 Hold ratings, and 0 Sell ratings. The MRUS average analyst price target in the past 3 months is $97.00.

  • Where Will Merus NV Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Merus NV share price will rise to $97.00 per share over the next 12 months.

  • What Do Analysts Say About Merus NV?

    Analysts are divided on their view about Merus NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Merus NV is a Sell and believe this share price will drop from its current level to $97.00.

  • What Is Merus NV's Price Target?

    The price target for Merus NV over the next 1-year time period is forecast to be $97.00 according to 16 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 14 analysts rate the stock a Hold.

  • Is MRUS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Merus NV is a Hold. 14 of 16 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of MRUS?

    You can purchase shares of Merus NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Merus NV shares.

  • What Is The Merus NV Share Price Today?

    Merus NV was last trading at $96.22 per share. This represents the most recent stock quote for Merus NV. Yesterday, Merus NV closed at $96.22 per share.

  • How To Buy Merus NV Stock Online?

    In order to purchase Merus NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
67
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
38
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
69
ASTS alert for Dec 5

AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock